Literature DB >> 34599042

Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis.

Andrea Angeletti1,2, Maurizio Bruschi1, Gabriella Moroni3, Renato Alberto Sinico4, Franco Franceschini5, Micaela Fredi5, Augusto Vaglio6,7, Lorenzo Cavagna8, Andrea Petretto9, Federico Pratesi10, Paola Migliorini10, Francesco Locatelli7, Giulia Pazzola11, Giampaola Pesce12, Marcello Bagnasco12, Angelo Manfredi13, Giuseppe A Ramirez13, Pasquale Esposito14, Giuseppe Murdaca15, Simone Negrini15, Leda Cipriani16, Barbara Trezzi4, Giacomo Emmi17, Ilaria Cavazzana5, Valentina Binda3, Matteo d'Alessandro2, Paride Fenaroli18, Isabella Pisani18, Giacomo Garibotto16, Carlomaurizio Montecucco8, Domenico Santoro19, Francesco Scolari20, Stefano Volpi21, Marta Mosca22, Angela Tincani5, Giovanni Candiano1, Marco Prunotto23, Enrico Verrina2, Angelo Ravelli21, Gian Marco Ghiggeri24,2.   

Abstract

Clinical Trial registry name and registration number: Zeus study, NCT02403115.
Copyright © 2021 by the American Society of Nephrology.

Entities:  

Keywords:  clinical trial; glomerulonephritis; lupus nephritis; rheumatology; systemic lupus erythematosus

Year:  2021        PMID： 34599042      PMCID： PMC8638388          DOI： 10.1681/ASN.2021050659

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


  5 in total

1.  Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis.

Authors:  Maurizio Bruschi; Gabriella Moroni; Renato Alberto Sinico; Franco Franceschini; Micaela Fredi; Augusto Vaglio; Lorenzo Cavagna; Andrea Petretto; Federico Pratesi; Paola Migliorini; Francesco Locatelli; Giulia Pazzola; Giampaola Pesce; Marcello Bagnasco; Angelo Manfredi; Giuseppe A Ramirez; Pasquale Esposito; Giuseppe Murdaca; Simone Negrini; Leda Cipriani; Barbara Trezzi; Giacomo Emmi; Ilaria Cavazzana; Valentina Binda; Paride Fenaroli; Isabella Pisani; Giacomo Garibotto; Carlomaurizio Montecucco; Domenico Santoro; Francesco Scolari; Marta Mosca; Angela Tincani; Giovanni Candiano; Marco Prunotto; Stefano Volpi; Enrico Verrina; Andrea Angeletti; Angelo Ravelli; Gian Marco Ghiggeri
Journal:  Rheumatology (Oxford)       Date:  2021-07-01       Impact factor: 7.580

2.  Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy.

Authors:  Nicola M Tomas; Elion Hoxha; Anna T Reinicke; Lars Fester; Udo Helmchen; Jens Gerth; Friederike Bachmann; Klemens Budde; Friedrich Koch-Nolte; Gunther Zahner; Gabriele Rune; Gerard Lambeau; Catherine Meyer-Schwesinger; Rolf A K Stahl
Journal:  J Clin Invest       Date:  2016-05-23       Impact factor: 14.808

3.  Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy.

Authors:  Gian Marco Ghiggeri; Barbara Seitz-Polski; Joana Justino; Christelle Zaghrini; Christine Payré; Vesna Brglez; Guillaume Dolla; Alberto Sinico; Francesco Scolari; Augusto Vaglio; Marco Prunotto; Giovanni Candiano; Antonella Radice; Maurizio Bruschi; Gérard Lambeau
Journal:  Clin J Am Soc Nephrol       Date:  2020-11-30       Impact factor: 8.237

4.  Mitochondrial-dependent Autoimmunity in Membranous Nephropathy of IgG4-related Disease.

Authors:  Simona Buelli; Luca Perico; Miriam Galbusera; Mauro Abbate; Marina Morigi; Rubina Novelli; Elena Gagliardini; Chiara Tentori; Daniela Rottoli; Ettore Sabadini; Takao Saito; Mitsuhiro Kawano; Takako Saeki; Carlamaria Zoja; Giuseppe Remuzzi; Ariela Benigni
Journal:  EBioMedicine       Date:  2015-03-06       Impact factor: 8.143

Review 5.  New 'Antigens' in Membranous Nephropathy.

Authors:  Sanjeev Sethi
Journal:  J Am Soc Nephrol       Date:  2020-12-30       Impact factor: 10.121
  5 in total
  2 in total

1.  Intravenous cyclophosphamide as an alternative to the oral cyclophosphamide modified Ponticelli regimen for high-risk PLA2R-positive membranous nephropathy.

Authors:  Gabriel Ștefan; Adrian Zugravu; Simona Stancu
Journal:  J Nephrol       Date:  2022-08-12       Impact factor: 4.393

2.  Discovery of anti-Formin-like 1 protein (FMNL1) antibodies in membranous nephropathy and other glomerular diseases.

Authors:  Maurizio Bruschi; Andrea Cavalli; Solange Moll; Giovanni Candiano; Leonardo Scapozza; Jigar J Patel; John C Tan; Ken C Lo; Andrea Angeletti; Gian Marco Ghiggeri; Marco Prunotto
Journal:  Sci Rep       Date:  2022-08-11       Impact factor: 4.996
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.